 Alain Cuna
Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchopulmonary Dysplasia | 15 | 2022 | 40 | 5.820 |
Why?
| | Enterocolitis, Necrotizing | 11 | 2023 | 67 | 5.370 |
Why?
| | Infant, Premature | 14 | 2024 | 85 | 3.600 |
Why?
| | Infant, Newborn | 26 | 2024 | 816 | 2.630 |
Why?
| | Infant, Newborn, Diseases | 4 | 2023 | 30 | 2.380 |
Why?
| | Glucocorticoids | 6 | 2021 | 32 | 2.350 |
Why?
| | Intestines | 3 | 2024 | 29 | 1.650 |
Why?
| | Dexamethasone | 4 | 2022 | 29 | 1.440 |
Why?
| | Humans | 28 | 2024 | 6896 | 1.390 |
Why?
| | Infant | 13 | 2023 | 1446 | 1.180 |
Why?
| | Genetic Predisposition to Disease | 3 | 2018 | 231 | 1.170 |
Why?
| | Retrospective Studies | 12 | 2022 | 1296 | 1.060 |
Why?
| | Gastrointestinal Microbiome | 2 | 2021 | 10 | 0.920 |
Why?
| | Artificial Intelligence | 1 | 2024 | 14 | 0.920 |
Why?
| | Toll-Like Receptors | 2 | 2023 | 14 | 0.920 |
Why?
| | Receptors, Interleukin-1 | 2 | 2020 | 9 | 0.850 |
Why?
| | Ultrasonography, Doppler | 2 | 2020 | 9 | 0.810 |
Why?
| | Ultrasonography | 2 | 2022 | 46 | 0.810 |
Why?
| | Steroids | 2 | 2020 | 16 | 0.780 |
Why?
| | Bacteria | 1 | 2021 | 9 | 0.750 |
Why?
| | Quality Improvement | 2 | 2020 | 60 | 0.750 |
Why?
| | Respiration, Artificial | 2 | 2018 | 17 | 0.730 |
Why?
| | Gestational Age | 6 | 2023 | 62 | 0.720 |
Why?
| | Animals | 7 | 2023 | 729 | 0.670 |
Why?
| | Anti-Inflammatory Agents | 1 | 2018 | 11 | 0.650 |
Why?
| | Pulmonary Alveoli | 2 | 2015 | 5 | 0.650 |
Why?
| | Female | 11 | 2022 | 3525 | 0.640 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2016 | 51 | 0.640 |
Why?
| | Genetic Loci | 1 | 2018 | 40 | 0.630 |
Why?
| | Male | 10 | 2019 | 3337 | 0.630 |
Why?
| | Genotype | 2 | 2018 | 410 | 0.600 |
Why?
| | Airway Extubation | 1 | 2017 | 1 | 0.600 |
Why?
| | Risk Assessment | 1 | 2018 | 137 | 0.590 |
Why?
| | Probiotics | 3 | 2023 | 10 | 0.590 |
Why?
| | Infant, Extremely Premature | 4 | 2019 | 14 | 0.580 |
Why?
| | Vaccination | 1 | 2017 | 71 | 0.570 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2016 | 7 | 0.570 |
Why?
| | Infant, Premature, Diseases | 1 | 2016 | 22 | 0.550 |
Why?
| | Genome-Wide Association Study | 2 | 2016 | 190 | 0.550 |
Why?
| | Length of Stay | 1 | 2017 | 233 | 0.540 |
Why?
| | DNA Methylation | 1 | 2015 | 115 | 0.480 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2014 | 6 | 0.470 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 8 | 0.470 |
Why?
| | Missouri | 3 | 2018 | 81 | 0.430 |
Why?
| | Signal Transduction | 3 | 2023 | 132 | 0.400 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2023 | 38 | 0.360 |
Why?
| | Inflammation | 3 | 2020 | 51 | 0.350 |
Why?
| | Mice | 4 | 2020 | 348 | 0.340 |
Why?
| | Prognosis | 2 | 2021 | 211 | 0.330 |
Why?
| | Tracheostomy | 2 | 2019 | 13 | 0.320 |
Why?
| | Intestinal Mucosa | 2 | 2020 | 41 | 0.310 |
Why?
| | Drug Administration Schedule | 2 | 2018 | 35 | 0.300 |
Why?
| | Sensitivity and Specificity | 2 | 2018 | 150 | 0.300 |
Why?
| | Treatment Outcome | 2 | 2018 | 622 | 0.260 |
Why?
| | Cohort Studies | 2 | 2018 | 289 | 0.250 |
Why?
| | Animals, Newborn | 3 | 2020 | 32 | 0.250 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 92 | 0.240 |
Why?
| | Adrenal Cortex Hormones | 2 | 2022 | 37 | 0.240 |
Why?
| | Dietary Supplements | 2 | 2023 | 25 | 0.230 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2016 | 348 | 0.230 |
Why?
| | Adult | 2 | 2018 | 1181 | 0.220 |
Why?
| | Cytokines | 2 | 2020 | 48 | 0.210 |
Why?
| | Apoptosis | 2 | 2020 | 52 | 0.210 |
Why?
| | Intensive Care, Neonatal | 1 | 2022 | 7 | 0.210 |
Why?
| | Infant Formula | 2 | 2020 | 15 | 0.210 |
Why?
| | Feasibility Studies | 1 | 2022 | 58 | 0.200 |
Why?
| | Lung Diseases | 1 | 2022 | 23 | 0.200 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2021 | 10 | 0.190 |
Why?
| | Risk Factors | 2 | 2021 | 487 | 0.190 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2021 | 2 | 0.190 |
Why?
| | Prebiotics | 1 | 2021 | 2 | 0.190 |
Why?
| | Dysbiosis | 1 | 2021 | 3 | 0.190 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 8 | 0.190 |
Why?
| | Administration, Inhalation | 1 | 2020 | 19 | 0.190 |
Why?
| | Kupffer Cells | 1 | 2020 | 3 | 0.180 |
Why?
| | Immunity, Innate | 2 | 2017 | 16 | 0.180 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 9 | 0.180 |
Why?
| | Ileum | 1 | 2020 | 15 | 0.180 |
Why?
| | Language Development | 1 | 2019 | 5 | 0.170 |
Why?
| | Cognition | 1 | 2019 | 32 | 0.170 |
Why?
| | Prednisolone | 1 | 2019 | 5 | 0.170 |
Why?
| | Mutation | 2 | 2017 | 212 | 0.160 |
Why?
| | Patient Outcome Assessment | 1 | 2018 | 8 | 0.160 |
Why?
| | Child | 3 | 2022 | 3364 | 0.150 |
Why?
| | Survival Analysis | 1 | 2018 | 50 | 0.150 |
Why?
| | Severity of Illness Index | 1 | 2018 | 149 | 0.150 |
Why?
| | Toll-Like Receptor 4 | 1 | 2017 | 11 | 0.150 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 99 | 0.150 |
Why?
| | Treatment Failure | 1 | 2017 | 16 | 0.150 |
Why?
| | Immunization Schedule | 1 | 2017 | 10 | 0.150 |
Why?
| | Infant, Extremely Low Birth Weight | 2 | 2014 | 9 | 0.150 |
Why?
| | Logistic Models | 1 | 2017 | 84 | 0.150 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 28 | 0.140 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 10 | 0.140 |
Why?
| | Hyperoxia | 1 | 2015 | 5 | 0.130 |
Why?
| | MicroRNAs | 1 | 2015 | 27 | 0.130 |
Why?
| | Genetic Variation | 1 | 2016 | 174 | 0.130 |
Why?
| | Gastrointestinal Contents | 1 | 2014 | 1 | 0.130 |
Why?
| | Epigenesis, Genetic | 1 | 2015 | 68 | 0.120 |
Why?
| | DNA | 1 | 2014 | 41 | 0.120 |
Why?
| | Enteral Nutrition | 1 | 2014 | 63 | 0.120 |
Why?
| | United States | 2 | 2023 | 669 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2017 | 71 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2023 | 85 | 0.050 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 336 | 0.050 |
Why?
| | Chronic Disease | 1 | 2022 | 105 | 0.050 |
Why?
| | Pilot Projects | 1 | 2022 | 120 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 274 | 0.050 |
Why?
| | Canada | 1 | 2021 | 31 | 0.050 |
Why?
| | Hospitals | 1 | 2021 | 36 | 0.050 |
Why?
| | Hospitals, Pediatric | 1 | 2022 | 187 | 0.050 |
Why?
| | Early Diagnosis | 1 | 2020 | 17 | 0.050 |
Why?
| | Language Development Disorders | 1 | 2019 | 4 | 0.040 |
Why?
| | Cognition Disorders | 1 | 2019 | 12 | 0.040 |
Why?
| | Child Development | 1 | 2019 | 44 | 0.040 |
Why?
| | Phosphorylation | 1 | 2017 | 22 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2017 | 35 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 20 | 0.040 |
Why?
| | Child, Preschool | 1 | 2022 | 1569 | 0.040 |
Why?
| | Fibroblasts | 1 | 2015 | 26 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2015 | 84 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2015 | 58 | 0.030 |
Why?
| | Perinatal Death | 1 | 2014 | 1 | 0.030 |
Why?
| | Intestinal Perforation | 1 | 2014 | 11 | 0.030 |
Why?
| | Milk, Human | 1 | 2014 | 23 | 0.030 |
Why?
| | Survival Rate | 1 | 2014 | 83 | 0.030 |
Why?
| | Incidence | 1 | 2014 | 133 | 0.030 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|